Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

Colon cancer is the second-deadliest cancer in the US, partly due to low screening rates. New and emerging screening tools, like blood and breath tests, may offer alternatives to in-office screenings.

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

Other colon cancer screening tests currently under development are at-home blood sample tests. Their low level of accuracy means they are currently not recommended for use in place of FOBT, FIT, or mt ...

In the United States, colorectal cancer is the fourth most common kind of cancer and the second-leading cause of cancer deaths, making screening very important.

SAN DIEGO — In the ever-expanding options for colorectal cancer (CRC) screening, blood tests using precision medicine are becoming more advanced and convenient than ever; however, caveats abound, and ...

Experts estimate that two-thirds of colorectal cancer deaths could be prevented with routine screenings, nursing instructor ...

Colonoscopy may be inconvenient and require planning, but the consequence and therapy for cancer is far more burdensome.